Prudential Financial’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.7K | Buy |
29,210
+2,870
| +11% | +$2.82K | ﹤0.01% | 2377 |
|
2025
Q1 | $37.9K | Sell |
26,340
-7,230
| -22% | -$10.4K | ﹤0.01% | 2219 |
|
2024
Q4 | $73.9K | Sell |
33,570
-16,000
| -32% | -$35.2K | ﹤0.01% | 2174 |
|
2024
Q3 | $81.8K | Buy |
49,570
+2,600
| +6% | +$4.29K | ﹤0.01% | 2598 |
|
2024
Q2 | $104K | Buy |
46,970
+14,910
| +47% | +$33.1K | ﹤0.01% | 2541 |
|
2024
Q1 | $85.9K | Sell |
32,060
-1,200
| -4% | -$3.22K | ﹤0.01% | 2541 |
|
2023
Q4 | $99.4K | Hold |
33,260
| – | – | ﹤0.01% | 2502 |
|
2023
Q3 | $32.6K | Buy |
+33,260
| New | +$32.6K | ﹤0.01% | 2542 |
|
2020
Q1 | – | Sell |
-3,683
| Closed | -$220K | – | 2381 |
|
2019
Q4 | $220K | Buy |
+3,683
| New | +$220K | ﹤0.01% | 2308 |
|